188 related articles for article (PubMed ID: 35453545)
1. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α
Sudha T; Godugu K; Glinsky GV; Mousa SA
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453545
[TBL] [Abstract][Full Text] [Related]
2. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204997
[TBL] [Abstract][Full Text] [Related]
3. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2019 Dec; 30(12):3087-3097. PubMed ID: 31714064
[TBL] [Abstract][Full Text] [Related]
4. Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management.
Sudha T; Godugu K; Darwish NHE; Nazeer T; Mousa SA
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439224
[TBL] [Abstract][Full Text] [Related]
5. Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.
Glinsky GV; Godugu K; Sudha T; Rajabi M; Chittur SV; Hercbergs AA; Mousa SA; Davis PJ
Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448512
[TBL] [Abstract][Full Text] [Related]
6. Discovery of dual targeting PEGylated BG-P
Ozen Karakus O; Godugu K; Mousa SA
Bioorg Med Chem; 2021 Aug; 43():116278. PubMed ID: 34157571
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme.
Godugu K; Hay BA; Glinsky GV; Mousa SA
Neurooncol Adv; 2023; 5(1):vdac180. PubMed ID: 36879662
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin α
Fujioka K; Hay BA; Godugu K; Mousa SA
Front Pharmacol; 2022; 13():902141. PubMed ID: 36518666
[TBL] [Abstract][Full Text] [Related]
9. Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma.
Karakus OO; Godugu K; Rajabi M; Mousa SA
J Med Chem; 2020 Jul; 63(14):7653-7662. PubMed ID: 32571015
[TBL] [Abstract][Full Text] [Related]
10. RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792024
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Efficacy and Mechanisms of a Dual Targeting of Norepinephrine Transporter and Thyrointegrin αvβ3 Antagonist in Neuroblastoma.
Godugu K; Karakus OO; Fujioka K; Glinsky GV; Mousa SA
J Cancer; 2022; 13(8):2594-2606. PubMed ID: 35711848
[No Abstract] [Full Text] [Related]
12. Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia.
Darwish NHE; Glinsky GV; Sudha T; Mousa SA
Front Oncol; 2021; 11():793810. PubMed ID: 35155195
[TBL] [Abstract][Full Text] [Related]
13. New Thyrointegrin α
Hay BA; Godugu K; Darwish NHE; Fujioka K; Sudha T; Karakus OO; Mousa SA
J Med Chem; 2021 May; 64(9):6300-6309. PubMed ID: 33886292
[TBL] [Abstract][Full Text] [Related]
14. Correction to "Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2021 Apr; 32(4):859. PubMed ID: 33689298
[No Abstract] [Full Text] [Related]
15. Correction to "Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2023 Feb; 34(2):453. PubMed ID: 36709499
[No Abstract] [Full Text] [Related]
16. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Rajabi M; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
[TBL] [Abstract][Full Text] [Related]
17. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
18. Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358892
[TBL] [Abstract][Full Text] [Related]
19. Nano-Targeting of Thyrointegrin αvβ3 Receptor in Solid Tumors and Impact on Radiosensitization.
Sudha T; Rehman MU; Darwish NHE; Coskun MD; Satti JA; Davis PJ; Mousa SA
Radiat Res; 2021 Oct; 196(4):375-385. PubMed ID: 34260732
[TBL] [Abstract][Full Text] [Related]
20. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
